Science:Chemistry
Proposed Regulatory Framework for Direct-to-Consumer Genetic Testing: Diagnostics vs Genetic Screening
2015-03-02
Download
Right click and do "save link as"
In December 2013 the genetics laboratory 23andMe stopped marketing direct-to-consumer disease predictive genetic testing in order to comply with a directive from the US Food and Drug Administration. The FDA's action was intended to protect the American public from questionable disease risk predictions.
More Episodes
Audio Summary March 2020
2020-02-26
2020-02-26
March 2020 Summary Guo
2020-02-26
2020-02-26
March 2020 Summary Hoffman
2020-02-26
2020-02-26
March 2020 Summary Blesa
2020-02-26
2020-02-26
March 2020 Summary Sun
2020-02-26
2020-02-26
March 2020 Summary Lam
2020-02-26
2020-02-26
March 2020 Summary Apple
2020-02-26
2020-02-26
February 2020 Summary Pruner
2020-01-29
2020-01-29
February 2020 Summary Jin
2020-01-29
2020-01-29
February 2020 Summary Malka
2020-01-29
2020-01-29
February 2020 Summary Vigneron
2020-01-29
2020-01-29
February 2020 Summary Ge
2020-01-29
2020-01-29
February 2020 Summary Starnberg
2020-01-29
2020-01-29
Get this podcast on your
phone, FREE
